PHAT Q1 2019 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$831M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-0.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$807,000

Free Cash Flow

-$807,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

-$1M

Cash & Equivalents

-$879,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$1M	-$253,000	-384.6%
Net Income	-$1M	-$257,000	-386.8%